News Focus
News Focus
Followers 28
Posts 617
Boards Moderated 0
Alias Born 08/25/2023

Re: williams45 post# 191

Wednesday, 11/06/2024 10:59:30 AM

Wednesday, November 06, 2024 10:59:30 AM

Post# of 300
NASDAQ: CRDL is advancing CardiolRx™ for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDL News